Physician

Sharon Louise Horton, M.D.

According to 2025 Medicare claims, Sharon Horton, M.D. (NPI: 1538153960) practices dermatology in the Elgin, IL market, with the plurality of this provider's patient population coming from Kane, IL. This provider's primary affiliated billing organization is SHARON L. HORTON, MD, PC (NPI: 1962525154; TIN: 364330159) and primary practice location at 60510-2478.

Horton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,592 traditional Medicare patients, billed 14,879 HCPCS/CPT codes, and received $1,224,845 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,881 prescription claims across 1,255 beneficiaries totaling $106,749 in drug costs, led by Jublia (Efinaconazole). Open Payments data shows 16 records totaling $340. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $154,772 to $106,749. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$612K$1.2M2015 Medicare payment: $1,050,385 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,040,045 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $941,143 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,018,310 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,042,290 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $897,796 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,061,106 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,050,272 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,095,167 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,224,845 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,02818,034$1,050,385
20162,02417,745$1,040,045
20171,97116,535$941,143
20182,06016,499$1,018,310
20191,92216,353$1,042,290
20201,73213,684$897,796
20211,79215,548$1,061,106
20221,86415,287$1,050,272
20231,84715,104$1,095,167
20241,59214,879$1,224,845

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$77K$155K2015 Drug cost: $154,772 (USD; Tot_Drug_Cst)2016 Drug cost: $135,135 (USD; Tot_Drug_Cst)2017 Drug cost: $115,462 (USD; Tot_Drug_Cst)2018 Drug cost: $101,481 (USD; Tot_Drug_Cst)2019 Drug cost: $82,615 (USD; Tot_Drug_Cst)2020 Drug cost: $85,891 (USD; Tot_Drug_Cst)2021 Drug cost: $79,482 (USD; Tot_Drug_Cst)2022 Drug cost: $78,118 (USD; Tot_Drug_Cst)2023 Drug cost: $113,928 (USD; Tot_Drug_Cst)2024 Drug cost: $106,749 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157311,580$154,772
20167841,714$135,135
20177681,649$115,462
20189001,867$101,481
20198981,792$82,615
20208421,929$85,891
20218632,048$79,482
20228751,903$78,118
20239722,151$113,928
20241,2552,881$106,749

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths744901$83
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,2081,439$62
11102Biopsy of related skin growth, first growth831980$57
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more6891,034$44
17000Destruction of precancer skin growth, 1 growth726933$36

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JubliaEfinaconazole11750$29,349
MetronidazoleMetronidazole1935,291$9,973
Betamethasone DipropionateBetamethasone Dipropionate2765,825$7,947
CalcipotrieneCalcipotriene30858$5,592
FluorouracilFluorouracil671,998$4,850

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$340Organogenesis Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sharon Louise Horton, M.D.?

Tedicare shows public-source Medicare data for Sharon Louise Horton, M.D. (NPI 1538153960), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sharon Louise Horton, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sharon Louise Horton, M.D.?

Sharon Louise Horton, M.D. is linked to SHARON L. HORTON, MD, PC (billing NPI 1962525154) in the available physician profile data.

Does Sharon Louise Horton, M.D. have Open Payments data?

Sharon Louise Horton, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.